Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis

地塞米松 心脏毒性 医学 蒽环类 随机对照试验 内科学 肿瘤科 药理学 化疗 癌症 乳腺癌
作者
Furqan Shaikh,L. Lee Dupuis,Sarah W. Alexander,Abha A. Gupta,Luc Mertens,Paul Craig Nathan
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:108 (4): djv357-djv357 被引量:181
标识
DOI:10.1093/jnci/djv357
摘要

BACKGROUND: Several randomized controlled trials (RCTs) have demonstrated that dexrazoxane reduces anthracycline cardiotoxicity in adults, but use in children has been hindered by lack of direct evidence of cardioprotection and concerns regarding second malignant neoplasms (SMNs). This study aimed to systematically review the evidence regarding dexrazoxane in children. METHODS: We searched Medline, Embase, the Cochrane Library, and abstracts for RCTs and nonrandomized studies (NRSs) that compared dexrazoxane to no cardioprotection among children. We combined findings using random-effects models. All statistical tests were two-sided. RESULTS: Eleven eligible publications reported results from five RCTs (1254 patients), and 15 publications reported results from 12 NRSs (3385 patients). Dexrazoxane did not impact clinical cardiotoxicity in RCTs because of a low cardiotoxic event rate (three events among all patients) but was associated with a reduction in subclinical cardiotoxicity. Among NRSs, dexrazoxane was associated with a reduction in clinical cardiotoxicity (relative risk (RR) = 0.29, P = .001) and clinical+subclinical cardiotoxicity (RR = 0.43, P < .001). Among RCTs, 17 of 635 (2.7%) patients treated with dexrazoxane developed an SMN compared with seven of 619 (1.1%) who did not receive dexrazoxane (RR = 2.37, P = .06). Two RCTs that used concurrent etoposide reported an increased risk of acute myeloid leukemia, while one that used cranial radiation reported an increased risk of brain tumors. Event-free survival did not differ (P = .91). CONCLUSION: Dexrazoxane is associated with a statistically significant risk reduction for most cardiotoxic outcomes. Dexrazoxane is associated with a statistically borderline increase in SMNs, possibly because of an interaction with concurrent cancer therapies. The decision to use dexrazoxane in children should balance the risks of cardiotoxicity and SMNs specific to each treatment protocol.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐的应助被lykkk采纳,获得10
刚刚
涵霸天完成签到,获得积分10
刚刚
Jun的应助被lykkk采纳,获得10
刚刚
李健的应助被lykkk采纳,获得10
刚刚
fantasy的应助被lykkk采纳,获得10
刚刚
可爱的函函的应助被lykkk采纳,获得10
刚刚
无花果的应助被lykkk采纳,获得10
刚刚
General发布了新的文献求助10
1秒前
懒狗发布了新的文献求助10
1秒前
涵霸天发布了新的文献求助30
2秒前
2秒前
科研通AI6.4的应助被fighting采纳,获得10
2秒前
所所的应助被1232采纳,获得10
2秒前
在水一方的应助被lykkk采纳,获得10
3秒前
吃猫的鱼发布了新的文献求助10
4秒前
4秒前
ZeKaWa的应助被nini采纳,获得10
5秒前
WJ完成签到,获得积分10
5秒前
跳跃的盼曼完成签到 ,获得积分10
6秒前
6秒前
6秒前
Akim的应助被wang采纳,获得10
7秒前
7秒前
DW的应助被朴实流沙采纳,获得10
8秒前
8秒前
赫尔忒发布了新的文献求助10
8秒前
xcltzh2517完成签到,获得积分10
9秒前
15348547697完成签到 ,获得积分10
9秒前
10秒前
10秒前
阿哲发布了新的文献求助10
11秒前
浮云发布了新的文献求助10
11秒前
时尚雪莲完成签到,获得积分10
11秒前
搞怪文轩完成签到,获得积分10
12秒前
CipherSage的应助被无题采纳,获得10
12秒前
RO完成签到,获得积分10
13秒前
wanci的应助被活佛济公采纳,获得10
13秒前
传奇3的应助被bcj_55采纳,获得10
13秒前
ZeKaWa的应助被Luxi采纳,获得10
13秒前
twive完成签到,获得积分20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175267
求助须知:如何正确求助?哪些是违规求助? 9567035
关于积分的说明 21789830
捐赠科研通 7769741
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556149
邀请新用户注册赠送积分活动 2477241